Company: NCEL
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065783
Chunk: 821

Company: NewcelX Ltd.
Filing Date: 2025-07-18
Form: F-4/A
Chunk 821
---
 the Company’s Board of Directors authorized a private placement of 20,000 non -marketableoptions to Prof. Efrat, exercisable for USD $5,340 (NIS 20,000 ) of Shares of the Company. The options will vest over a period of 4 years and can be exercised until January 22, 2025, at an exercise price per share of USD $1.80. As of December 31, 2024, the Company has no royalties liability in respect of the agreement. F.On May 4, 2023, the Company and iTolerance, Inc. (hereinafter, “iTolerance”) signed a cooperation agreement for the implementation of the project (hereinafter, the “Cooperation Agreement”), and on May 8, 2023, the Company, iTolerance, and the BIRD foundation signed a funding project and cooperation agreement (hereinafter, the “BIRD agreement,” and with the Cooperation Agreement, the “Agreements”). The Agreements were signed in connection with obtaining the approval of the BIRD foundation, a binational Israeli and US R&D fund, whose purpose is to encourage and support industrial collaborations between Israeli and US companies (hereinafter, the “BIRD Foundation”) for the receipt of a grant totaling USD $1 million (hereinafter, the “Grant”), which would be divided between the parties in equal parts, to support the joint development of an innovative treatment in the field of diabetes by the Company and iTolerance, with a total budget of USD $2 million for a period of 30 months (hereinafter, the “Grant period”). The total grants received in 2024 from the BIRD Foundation are USD $250 thousand. As of December 31, 2024, the Company has an outstanding balance of USD $42 thousand in respect of deferred receivables from the BIRD Foundation. G.On February 14, 2024, the Company entered into a non -bindingmemorandum of understanding (hereinafter, the “MOU”) for a merger with IMC Corp (Nasdaq: “IMCC”), a company whose shares are traded in the United States on the Nasdaq Stock Market and in Canada on the Canadian Securities Exchange (CNSX) (hereinafter, the “IMC”). IMC is incorporated under the laws of Canada. On May 27, 2024, negotiations between the parties to sign a final agreement were terminated, inter alia,